NasdaqGM - Nasdaq Real Time Price • USD
Tandem Diabetes Care, Inc. (TNDM)
As of 10:02 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | -0.76 | -0.5 | -1.59 | -1.09 |
| Low Estimate | -0.85 | -0.65 | -1.96 | -1.44 |
| High Estimate | -0.58 | -0.35 | -1.36 | -0.7 |
| Year Ago EPS | -0.63 | -0.3 | -1.6 | -1.59 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 15 | 17 | 16 |
| Avg. Estimate | 174.02M | 205.03M | 845.31M | 942.58M |
| Low Estimate | 166M | 192M | 799M | 903.62M |
| High Estimate | 179.8M | 220.15M | 852.29M | 1.01B |
| Year Ago Sales | 170.23M | 197.36M | 747.72M | 845.31M |
| Sales Growth (year/est) | 2.20% | 3.90% | 13.10% | 11.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.52 | -0.53 | -0.34 | -0.25 |
| EPS Actual | -0.63 | -0.3 | -0.38 | -0.27 |
| Difference | -0.11 | 0.23 | -0.04 | -0.02 |
| Surprise % | -21.20% | 43.40% | -11.80% | -8.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.76 | -0.5 | -1.59 | -1.09 |
| 7 Days Ago | -0.76 | -0.5 | -1.59 | -1.09 |
| 30 Days Ago | -0.75 | -0.51 | -1.61 | -1.09 |
| 60 Days Ago | -0.47 | -0.38 | -1.25 | -0.83 |
| 90 Days Ago | -0.47 | -0.38 | -1.25 | -0.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TNDM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -20.60% | -- | -- | 0.80% |
| Next Qtr. | -66.70% | -- | -- | 9.60% |
| Current Year | 0.60% | -- | -- | 4.50% |
| Next Year | 31.40% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -47.40% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 |
| Upgrade | Stifel: Hold to Buy | 3/26/2024 |
| Maintains | Citigroup: Neutral to Neutral | 3/15/2024 |
| Maintains | Stifel: Hold to Hold | 2/5/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/2/2023 |
| Initiated | Leerink Partners: Market Perform | 10/16/2023 |
Related Tickers
PODD Insulet Corporation
166.16
+0.87%
DXCM DexCom, Inc.
133.76
-0.40%
SENS Senseonics Holdings, Inc.
0.4139
-0.50%
GKOS Glaukos Corporation
96.03
+0.95%
INSP Inspire Medical Systems, Inc.
244.62
+1.44%
OM Outset Medical, Inc.
2.2800
+1.33%
NVCR NovoCure Limited
12.21
+1.33%
CNMD CONMED Corporation
71.84
+1.07%
UFPT UFP Technologies, Inc.
218.35
+0.28%
SRTS Sensus Healthcare, Inc.
3.2500
0.00%